Trial Profile
A study to evaluate the efficacy of abatacept versus TNF inhibitors in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Adalimumab; Etanercept; Golimumab; Infliximab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 22 Jul 2015 New trial record